SlideShare una empresa de Scribd logo
1 de 4
Descargar para leer sin conexión
MediPoint: Sports Medicine - US Analysis and Market Forecasts
MediPoint: Sports Medicine - US Analysis and Market Forecasts
Summary
This report focuses on the sports medicine market, which includes implants and arthroscopic capital equipment. The orthopedic sports medicine market has been
estimated in this report and covers the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India. The report provides unmet needs, future
adoption and compound annual growth rates (CAGR). GlobalDatas analysis shows that while the orthopedics implant market is mature, sports medicine is an area
with the potential for significant international growth. With the market, the US remains to be the largest market with the EU to follow and growing. The APAC
region while markedly smaller has a large potential patient population.The top six to seven market leaders continue to dominate the market through technological
innovation and investment in establishing strong distribution networks. The major opportunity lies within technological advancement and the clinical trials to
prove effectiveness of new techniques.
The US sports medicine market is a strong and growing market, with prevalence of sports-related injury rising most rapidly among the young and old. The
biggest player in sports medicine in the US remains Arthrex, leading with a 21% market share. This company has the strongest brand identity and offers a wide
selection of products, which makes it competitive and able to maintain its market share.
Scope
- An overview of sports medicine, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized the US sports medicine market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.
- Investigation of current and future market competition for sports medicine.
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval
timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the sports medicine sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists
Reasons to buy
- Understand the trends shaping and driving the US sports medicine market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in the US sports medicine market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the markets device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- Whats the next big thing in the US sports medicine market landscape? Identify, understand and capitalize.
2.2 Related Reports 22
2.3 Upcoming Related Reports 22
3 Clinical Outcomes 23
3.1 Conservative Treatments 23
3.1.1 Immobilization And Bracing 24
3.1.2 Physical Therapy 24
3.1.3 Muscle Stimulation 25
3.2 Drug Therapy 25
3.2.1 Nutritional Supplements 26
3.2.2 Analgesics And Nsaids 26
3.2.3 Corticosteroids 26
3.2.4 Viscosupplementation 26
3.3 Soft Tissue Repair 27
3.4 Arthroscopy 29
3.5 Plates And Screws 30
3.6 Joint Replacement 30
4 Industry Overview 32
MediPoint: Sports Medicine - US Analysis and Market Forecasts
4.1 Overview 32
4.2 Procedure Trends 33
4.2.1 Us 33
4.3 Market Access 35
4.3.1 Us 35
4.4 Disputes And Settlements 40
4.4.1 Smith & Nephew Granted An Injunction Against Arthrex 40
4.4.2 Kfx Medical And Smith & Nephew Enter Into Licensing Agreement 40
4.4.3 Kfx Medical Wins Patent Infringement Lawsuit Against Arthrex 40
4.4.4 Arthrocare And Smith & Nephew Settle Legal Disputes 40
4.5 Mergers, Acquisitions, Partnerships, And Other Deals 40
4.5.1 Stryker Acquires Pivot Medical 40
4.5.2 Smith & Nephew Announces Acquisition Of Arthrocare 41
4.5.3 Smith & Nephew Acquires Plato Grup Assets 41
4.5.4 Smith & Nephew Announces Acquisition Of Its Brazil Distribution Business 41
4.5.5 Kensey Nash Acquires Minority Stake In Orteq Sports Medicine 41
4.5.6 Tornier Acquires C2m Medical 42
4.5.7 Tornier Signs Licensing Agreement With T.a.g. Medical Products Corporation 42
4.5.8 Biomet Acquires Cartilix 42
4.5.9 Biomet Sports Medicine Enters Into Deal With Marc Tec 42
4.6 Economic Impact 42
4.6.1 Developed Countries 42
4.6.2 Emerging Markets 45
5 Unmet Needs 46
5.1 Long-term Clinical Data 46
5.1.1 Hip Arthroscopic Implants Clinical Data 46
5.1.2 Rotator Cuff Injury Clinical Data 46
5.2 Cartilage And Meniscal Repair Product Development 47
5.2.1 Knee Meniscus Treatment 47
5.2.2 Hip Cartilage Product Development 49
5.3 Biologics For Faster Healing 50
5.4 Standardization And Improvement Of Instruments 51
5.4.1 Hip And Shoulder Instrumentation 51
5.4.2 Screwdriver Standardization 51
5.5 Fellowship Training Programs 52
5.6 Advanced Materials Research 53
5.7 Bioabsorbable Technology Development 54
5.8 Centralization 56
5.9 Need For Cost-containment 56
5.10 Suture Anchor Product Development 57
6 Market Opportunity Analysis 59
6.1 Adding More Training Programs 59
6.2 Product Line Extensions 59
6.3 Lack Of Pricing Pressure In Sports Medicine 60
6.4 Mergers And Acquisitions 61
6.5 Seasonality Of Sports Medicine 62
6.6 Emerging Markets 62
6.7 Minimally-invasive Surgical Preference 63
7 Market Drivers, Barriers And Substitutes 64
7.1 Driver: Rising Prevalence 64
7.1.1 Sports-related Injuries 64
7.1.2 Aging 64
7.1.3 Trauma 65
7.2 Driver: Hip Arthroscopy 66
7.2.1 Femoroacetabular Impingement Growth 67
7.2.2 Hip Arthroscopy Fellowship Training Programs 68
7.3 Driver: Knee And Shoulder Arthroscopy 68
7.4 Driver: Revision Surgery 69
7.5 Driver: Patient Demand And Awareness 70
7.6 Driver: Orthobiologics Development 71
7.6.1 Bone Grafts 71
7.6.2 Platelet-rich Plasma 72
7.7 Driver: Rising Competition And Innovation Through Small Players 72
7.8 Driver: Materials Development 72
7.8.1 Composite Materials And Biopolymers 73
7.8.2 Bioabsorbables 73
7.8.3 Metallic Alloys In Orthopedics 74
7.9 Barrier: Arthroscopys Questionable Outcomes 75
MediPoint: Sports Medicine - US Analysis and Market Forecasts
7.9.1 Hip Arthroscopy 75
7.9.2 Knee Arthroscopy 76
7.10 Barrier: Steep Learning Curve 77
7.11 Barrier: Reimbursement 77
7.12 Barrier: Burden Of Rising Regulation 79
7.13 Barrier: Proving Efficacy 80
7.14 Barrier: Medical Device Excise Tax 81
7.15 Substitute: Open Surgery Versus Minimally-invasive Arthroscopy 81
7.16 Substitute: Conservative Treatment Options 82
8 Competitive Assessment 83
8.1 Overview 83
8.2 Marketed Products In Sports Medicine 83
8.2.1 Arthrex 83
8.2.2 Arthrocare Corporation 90
8.2.3 Biomet 94
8.2.4 Conmed Corporation 98
8.2.5 Depuy Mitek 103
8.2.6 Smith & Nephew 106
8.2.7 Stryker 109
8.2.8 Tornier 111
9 Pipeline Assessment 113
9.1 Overview 113
9.2 Product Profiles 113
9.2.1 Bioretec Drug-releasing Screws 113
9.2.2 Nanova Bioabsorbable Bone Screws 113
9.2.3 Mininvasive Arthroscopic Suture Passer 113
9.2.4 Spinesmith Pipeline 114
9.2.5 Depuy Mitek Fms Vue 114
9.2.6 Pivot Medical Hip Arthroscopy System 114
9.2.7 University Of Florida Shoulder Labral Anchor Delivery System 114
9.2.8 University Of California At San Diego Cartilage Regeneration Device 114
10 Clinical Trials To Watch 115
10.1 Overview 115
10.2 Can Shoulder Arthroscopy Work (csaw) Study 115
10.3 Arthroscopy In The Treatment Of Degenerative Medial Meniscus Tear 115
10.4 Knee Arthroscopy Cohort Southern Denmark 116
10.5 Hip Arthroscopy Versus Conservative Management Of Femoroacetabular Impingement 116
10.6 Femoroacetabular Impingement Randomized Controlled Trial 117
10.7 Multicenter Acl Revision Study (mars) 117
10.8 Arthroscopic Versus Open Stabilization For Traumatic Shoulder Instability 118
10.9 Microfracture In The Knee Study 118
10.10 Single- Versus Double-row Suture Anchor Repair In Medium To Large Rotator Cuff Tears 119
10.11 Early Surgery Versus Conservative Therapy For Meniscal Injuries In Older Patients (escape) 119
10.12 Arthroscopic Rotator Cuff Repair Of Full Thickness Tears With And Without Arthroscopic Acromioplasty 120
10.13 Arthroscopic Rotator Cuff Repair With Platelet-rich Plasma 121
10.14 Tibial Tunnel Widening In Acl Reconstruction-comparing Two Bioscrews 121
11 Current And Future Players 122
11.1 Trends In Corporate Strategy 122
11.2 Company Profiles 123
11.2.1 Arthrex 123
11.2.2 Arthrocare Corporation 125
11.2.3 Biomet 127
11.2.4 Conmed Corporation 130
11.2.5 Depuy Companies 132
11.2.6 Smith & Nephew 134
11.2.7 Stryker 136
11.2.8 Tornier 138
11.2.9 Wright Medical Group 141
11.2.10 Other Key Players In Sports Medicine 144
12 Market Outlook 149
12.1 Company Market Share 149
12.1.1 Overview 149
12.1.2 Us 149
12.2 Us Market Outlook 150
13 Appendix 153
13.1 Bibliography 153
13.2 Abbreviations 162
13.3 Research Methodology 166
MediPoint: Sports Medicine - US Analysis and Market Forecasts
13.3.1 Overview 166
13.3.2 Coverage 166
13.3.3 Secondary Research 166
13.4 Physicians And Specialists Included In This Study 167
13.4.1 Dr. Henry D.e. Atkinson 167
13.4.2 Dr. Joshua Alpert 167
13.4.3 Dr. Andrea Ferretti 167
13.4.4 Dr. Alejandro Gonzalez Della Valle 168
13.4.5 Dr. Andreas Imhoff 168
13.4.6 Dr. Marcello Zaia Oliveira 168
13.4.7 Dr. Vidhya Ravi 168
13.4.8 Dr. Elvire Servien 168
13.4.9 Dr. Yotaro Yamakado 168
13.5 Primary Research 169
13.5.1 Primary Research - Key Opinion Leader Interviews 169
13.5.2 Primary Research - Physician And Industry Interviews 169
13.5.3 Expert Panel Validation 170
13.6 Forecasting Methodology 170
13.7 About The Authors 172
13.7.1 Analysts 172
13.7.2 Global Head Of Healthcare 173
13.8 About Medipoint 174
13.9 About Globaldata 174
13.10 Disclaimer 174
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
MediPoint: Sports Medicine - US Analysis and Market Forecasts

Más contenido relacionado

Más de Ambikabasa

Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma   pipeline review, h1 2015Rhabdomyosarcoma   pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015Ambikabasa
 
Raynauds disease pipeline review, h1 2015
Raynauds disease   pipeline review, h1 2015Raynauds disease   pipeline review, h1 2015
Raynauds disease pipeline review, h1 2015Ambikabasa
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea   pipeline review, h1 2015Travelers diarrhea   pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015Ambikabasa
 
Herpes zoster (shingles) pipeline review, h1 2015
Herpes zoster (shingles)   pipeline review, h1 2015Herpes zoster (shingles)   pipeline review, h1 2015
Herpes zoster (shingles) pipeline review, h1 2015Ambikabasa
 
Emphysema pipeline review, h1 2015
Emphysema   pipeline review, h1 2015Emphysema   pipeline review, h1 2015
Emphysema pipeline review, h1 2015Ambikabasa
 
Cerebral infarction (brain infarction) pipeline review, h1 2015
Cerebral infarction (brain infarction)   pipeline review, h1 2015Cerebral infarction (brain infarction)   pipeline review, h1 2015
Cerebral infarction (brain infarction) pipeline review, h1 2015Ambikabasa
 
Seborrhea pipeline review, h1 2015
Seborrhea   pipeline review, h1 2015Seborrhea   pipeline review, h1 2015
Seborrhea pipeline review, h1 2015Ambikabasa
 
Respiratory depression pipeline review, h1 2015
Respiratory depression   pipeline review, h1 2015Respiratory depression   pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015Ambikabasa
 
H1 n1 infection pipeline review, h1 2015
H1 n1 infection   pipeline review, h1 2015H1 n1 infection   pipeline review, h1 2015
H1 n1 infection pipeline review, h1 2015Ambikabasa
 
Nicotine addiction pipeline review, h1 2015
Nicotine addiction   pipeline review, h1 2015Nicotine addiction   pipeline review, h1 2015
Nicotine addiction pipeline review, h1 2015Ambikabasa
 
Food allergy pipeline review, h1 2015
Food allergy   pipeline review, h1 2015Food allergy   pipeline review, h1 2015
Food allergy pipeline review, h1 2015Ambikabasa
 
Uveal melanoma pipeline review, h1 2015
Uveal melanoma   pipeline review, h1 2015Uveal melanoma   pipeline review, h1 2015
Uveal melanoma pipeline review, h1 2015Ambikabasa
 
Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag   product pipeline review - 2015Tillotts pharma ag   product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015Ambikabasa
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc.   product pipeline review - 2015Co mentis, inc.   product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015Ambikabasa
 
Therapure biopharma inc. product pipeline review - 2015
Therapure biopharma inc.   product pipeline review - 2015Therapure biopharma inc.   product pipeline review - 2015
Therapure biopharma inc. product pipeline review - 2015Ambikabasa
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation   product pipeline review - 2015Genzyme corporation   product pipeline review - 2015
Genzyme corporation product pipeline review - 2015Ambikabasa
 
Quantum genomics sa product pipeline review - 2015
Quantum genomics sa   product pipeline review - 2015Quantum genomics sa   product pipeline review - 2015
Quantum genomics sa product pipeline review - 2015Ambikabasa
 
Brain cancer pipeline review, h1 2015
Brain cancer   pipeline review, h1 2015Brain cancer   pipeline review, h1 2015
Brain cancer pipeline review, h1 2015Ambikabasa
 
Diarrhea pipeline review, h1 2015
Diarrhea   pipeline review, h1 2015Diarrhea   pipeline review, h1 2015
Diarrhea pipeline review, h1 2015Ambikabasa
 
Integra gen s.a (alint) product pipeline analysis, 2014 update
Integra gen s.a (alint)   product pipeline analysis, 2014 updateIntegra gen s.a (alint)   product pipeline analysis, 2014 update
Integra gen s.a (alint) product pipeline analysis, 2014 updateAmbikabasa
 

Más de Ambikabasa (20)

Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma   pipeline review, h1 2015Rhabdomyosarcoma   pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015
 
Raynauds disease pipeline review, h1 2015
Raynauds disease   pipeline review, h1 2015Raynauds disease   pipeline review, h1 2015
Raynauds disease pipeline review, h1 2015
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea   pipeline review, h1 2015Travelers diarrhea   pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015
 
Herpes zoster (shingles) pipeline review, h1 2015
Herpes zoster (shingles)   pipeline review, h1 2015Herpes zoster (shingles)   pipeline review, h1 2015
Herpes zoster (shingles) pipeline review, h1 2015
 
Emphysema pipeline review, h1 2015
Emphysema   pipeline review, h1 2015Emphysema   pipeline review, h1 2015
Emphysema pipeline review, h1 2015
 
Cerebral infarction (brain infarction) pipeline review, h1 2015
Cerebral infarction (brain infarction)   pipeline review, h1 2015Cerebral infarction (brain infarction)   pipeline review, h1 2015
Cerebral infarction (brain infarction) pipeline review, h1 2015
 
Seborrhea pipeline review, h1 2015
Seborrhea   pipeline review, h1 2015Seborrhea   pipeline review, h1 2015
Seborrhea pipeline review, h1 2015
 
Respiratory depression pipeline review, h1 2015
Respiratory depression   pipeline review, h1 2015Respiratory depression   pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015
 
H1 n1 infection pipeline review, h1 2015
H1 n1 infection   pipeline review, h1 2015H1 n1 infection   pipeline review, h1 2015
H1 n1 infection pipeline review, h1 2015
 
Nicotine addiction pipeline review, h1 2015
Nicotine addiction   pipeline review, h1 2015Nicotine addiction   pipeline review, h1 2015
Nicotine addiction pipeline review, h1 2015
 
Food allergy pipeline review, h1 2015
Food allergy   pipeline review, h1 2015Food allergy   pipeline review, h1 2015
Food allergy pipeline review, h1 2015
 
Uveal melanoma pipeline review, h1 2015
Uveal melanoma   pipeline review, h1 2015Uveal melanoma   pipeline review, h1 2015
Uveal melanoma pipeline review, h1 2015
 
Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag   product pipeline review - 2015Tillotts pharma ag   product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc.   product pipeline review - 2015Co mentis, inc.   product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015
 
Therapure biopharma inc. product pipeline review - 2015
Therapure biopharma inc.   product pipeline review - 2015Therapure biopharma inc.   product pipeline review - 2015
Therapure biopharma inc. product pipeline review - 2015
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation   product pipeline review - 2015Genzyme corporation   product pipeline review - 2015
Genzyme corporation product pipeline review - 2015
 
Quantum genomics sa product pipeline review - 2015
Quantum genomics sa   product pipeline review - 2015Quantum genomics sa   product pipeline review - 2015
Quantum genomics sa product pipeline review - 2015
 
Brain cancer pipeline review, h1 2015
Brain cancer   pipeline review, h1 2015Brain cancer   pipeline review, h1 2015
Brain cancer pipeline review, h1 2015
 
Diarrhea pipeline review, h1 2015
Diarrhea   pipeline review, h1 2015Diarrhea   pipeline review, h1 2015
Diarrhea pipeline review, h1 2015
 
Integra gen s.a (alint) product pipeline analysis, 2014 update
Integra gen s.a (alint)   product pipeline analysis, 2014 updateIntegra gen s.a (alint)   product pipeline analysis, 2014 update
Integra gen s.a (alint) product pipeline analysis, 2014 update
 

Último

Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort ServiceCall US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Servicecallgirls2057
 
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...ictsugar
 
Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Kirill Klimov
 
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / NcrCall Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncrdollysharma2066
 
APRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfAPRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfRbc Rbcua
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCRashishs7044
 
Organizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessOrganizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessSeta Wicaksana
 
Buy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy Verified Accounts
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCRashishs7044
 
Memorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMMemorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMVoces Mineras
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfrichard876048
 
Kenya’s Coconut Value Chain by Gatsby Africa
Kenya’s Coconut Value Chain by Gatsby AfricaKenya’s Coconut Value Chain by Gatsby Africa
Kenya’s Coconut Value Chain by Gatsby Africaictsugar
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCRashishs7044
 
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu MenzaYouth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu Menzaictsugar
 
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCRashishs7044
 
Kenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith PereraKenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith Pereraictsugar
 
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdfNewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdfKhaled Al Awadi
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfJos Voskuil
 
Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Anamaria Contreras
 

Último (20)

Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort ServiceCall US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
Call US-88OO1O2216 Call Girls In Mahipalpur Female Escort Service
 
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
 
Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024
 
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / NcrCall Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
 
APRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfAPRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdf
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
 
Organizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessOrganizational Structure Running A Successful Business
Organizational Structure Running A Successful Business
 
Buy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail AccountsBuy gmail accounts.pdf Buy Old Gmail Accounts
Buy gmail accounts.pdf Buy Old Gmail Accounts
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
 
Memorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMMemorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQM
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdf
 
Kenya’s Coconut Value Chain by Gatsby Africa
Kenya’s Coconut Value Chain by Gatsby AfricaKenya’s Coconut Value Chain by Gatsby Africa
Kenya’s Coconut Value Chain by Gatsby Africa
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
 
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu MenzaYouth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
Youth Involvement in an Innovative Coconut Value Chain by Mwalimu Menza
 
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
 
Kenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith PereraKenya Coconut Production Presentation by Dr. Lalith Perera
Kenya Coconut Production Presentation by Dr. Lalith Perera
 
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdfNewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
 
Corporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information TechnologyCorporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information Technology
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdf
 
Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.Traction part 2 - EOS Model JAX Bridges.
Traction part 2 - EOS Model JAX Bridges.
 

Medi point sports medicine - us analysis and market forecasts

  • 1. MediPoint: Sports Medicine - US Analysis and Market Forecasts MediPoint: Sports Medicine - US Analysis and Market Forecasts Summary This report focuses on the sports medicine market, which includes implants and arthroscopic capital equipment. The orthopedic sports medicine market has been estimated in this report and covers the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India. The report provides unmet needs, future adoption and compound annual growth rates (CAGR). GlobalDatas analysis shows that while the orthopedics implant market is mature, sports medicine is an area with the potential for significant international growth. With the market, the US remains to be the largest market with the EU to follow and growing. The APAC region while markedly smaller has a large potential patient population.The top six to seven market leaders continue to dominate the market through technological innovation and investment in establishing strong distribution networks. The major opportunity lies within technological advancement and the clinical trials to prove effectiveness of new techniques. The US sports medicine market is a strong and growing market, with prevalence of sports-related injury rising most rapidly among the young and old. The biggest player in sports medicine in the US remains Arthrex, leading with a 21% market share. This company has the strongest brand identity and offers a wide selection of products, which makes it competitive and able to maintain its market share. Scope - An overview of sports medicine, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the US sports medicine market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018. - Investigation of current and future market competition for sports medicine. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the sports medicine sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists Reasons to buy - Understand the trends shaping and driving the US sports medicine market. - Realize device preferences of physicians who have performed the tests already. - Access market sizing, forecasts and quantified growth opportunities in the US sports medicine market through 2018. - Quantify candidate patient populations to better design product pricing & launch plans. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Perform benchmarking analysis of growth opportunities against currently marketed products. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Take a comprehensive look at the markets device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. - Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth. - Whats the next big thing in the US sports medicine market landscape? Identify, understand and capitalize. 2.2 Related Reports 22 2.3 Upcoming Related Reports 22 3 Clinical Outcomes 23 3.1 Conservative Treatments 23 3.1.1 Immobilization And Bracing 24 3.1.2 Physical Therapy 24 3.1.3 Muscle Stimulation 25 3.2 Drug Therapy 25 3.2.1 Nutritional Supplements 26 3.2.2 Analgesics And Nsaids 26 3.2.3 Corticosteroids 26 3.2.4 Viscosupplementation 26 3.3 Soft Tissue Repair 27 3.4 Arthroscopy 29 3.5 Plates And Screws 30 3.6 Joint Replacement 30 4 Industry Overview 32 MediPoint: Sports Medicine - US Analysis and Market Forecasts
  • 2. 4.1 Overview 32 4.2 Procedure Trends 33 4.2.1 Us 33 4.3 Market Access 35 4.3.1 Us 35 4.4 Disputes And Settlements 40 4.4.1 Smith & Nephew Granted An Injunction Against Arthrex 40 4.4.2 Kfx Medical And Smith & Nephew Enter Into Licensing Agreement 40 4.4.3 Kfx Medical Wins Patent Infringement Lawsuit Against Arthrex 40 4.4.4 Arthrocare And Smith & Nephew Settle Legal Disputes 40 4.5 Mergers, Acquisitions, Partnerships, And Other Deals 40 4.5.1 Stryker Acquires Pivot Medical 40 4.5.2 Smith & Nephew Announces Acquisition Of Arthrocare 41 4.5.3 Smith & Nephew Acquires Plato Grup Assets 41 4.5.4 Smith & Nephew Announces Acquisition Of Its Brazil Distribution Business 41 4.5.5 Kensey Nash Acquires Minority Stake In Orteq Sports Medicine 41 4.5.6 Tornier Acquires C2m Medical 42 4.5.7 Tornier Signs Licensing Agreement With T.a.g. Medical Products Corporation 42 4.5.8 Biomet Acquires Cartilix 42 4.5.9 Biomet Sports Medicine Enters Into Deal With Marc Tec 42 4.6 Economic Impact 42 4.6.1 Developed Countries 42 4.6.2 Emerging Markets 45 5 Unmet Needs 46 5.1 Long-term Clinical Data 46 5.1.1 Hip Arthroscopic Implants Clinical Data 46 5.1.2 Rotator Cuff Injury Clinical Data 46 5.2 Cartilage And Meniscal Repair Product Development 47 5.2.1 Knee Meniscus Treatment 47 5.2.2 Hip Cartilage Product Development 49 5.3 Biologics For Faster Healing 50 5.4 Standardization And Improvement Of Instruments 51 5.4.1 Hip And Shoulder Instrumentation 51 5.4.2 Screwdriver Standardization 51 5.5 Fellowship Training Programs 52 5.6 Advanced Materials Research 53 5.7 Bioabsorbable Technology Development 54 5.8 Centralization 56 5.9 Need For Cost-containment 56 5.10 Suture Anchor Product Development 57 6 Market Opportunity Analysis 59 6.1 Adding More Training Programs 59 6.2 Product Line Extensions 59 6.3 Lack Of Pricing Pressure In Sports Medicine 60 6.4 Mergers And Acquisitions 61 6.5 Seasonality Of Sports Medicine 62 6.6 Emerging Markets 62 6.7 Minimally-invasive Surgical Preference 63 7 Market Drivers, Barriers And Substitutes 64 7.1 Driver: Rising Prevalence 64 7.1.1 Sports-related Injuries 64 7.1.2 Aging 64 7.1.3 Trauma 65 7.2 Driver: Hip Arthroscopy 66 7.2.1 Femoroacetabular Impingement Growth 67 7.2.2 Hip Arthroscopy Fellowship Training Programs 68 7.3 Driver: Knee And Shoulder Arthroscopy 68 7.4 Driver: Revision Surgery 69 7.5 Driver: Patient Demand And Awareness 70 7.6 Driver: Orthobiologics Development 71 7.6.1 Bone Grafts 71 7.6.2 Platelet-rich Plasma 72 7.7 Driver: Rising Competition And Innovation Through Small Players 72 7.8 Driver: Materials Development 72 7.8.1 Composite Materials And Biopolymers 73 7.8.2 Bioabsorbables 73 7.8.3 Metallic Alloys In Orthopedics 74 7.9 Barrier: Arthroscopys Questionable Outcomes 75 MediPoint: Sports Medicine - US Analysis and Market Forecasts
  • 3. 7.9.1 Hip Arthroscopy 75 7.9.2 Knee Arthroscopy 76 7.10 Barrier: Steep Learning Curve 77 7.11 Barrier: Reimbursement 77 7.12 Barrier: Burden Of Rising Regulation 79 7.13 Barrier: Proving Efficacy 80 7.14 Barrier: Medical Device Excise Tax 81 7.15 Substitute: Open Surgery Versus Minimally-invasive Arthroscopy 81 7.16 Substitute: Conservative Treatment Options 82 8 Competitive Assessment 83 8.1 Overview 83 8.2 Marketed Products In Sports Medicine 83 8.2.1 Arthrex 83 8.2.2 Arthrocare Corporation 90 8.2.3 Biomet 94 8.2.4 Conmed Corporation 98 8.2.5 Depuy Mitek 103 8.2.6 Smith & Nephew 106 8.2.7 Stryker 109 8.2.8 Tornier 111 9 Pipeline Assessment 113 9.1 Overview 113 9.2 Product Profiles 113 9.2.1 Bioretec Drug-releasing Screws 113 9.2.2 Nanova Bioabsorbable Bone Screws 113 9.2.3 Mininvasive Arthroscopic Suture Passer 113 9.2.4 Spinesmith Pipeline 114 9.2.5 Depuy Mitek Fms Vue 114 9.2.6 Pivot Medical Hip Arthroscopy System 114 9.2.7 University Of Florida Shoulder Labral Anchor Delivery System 114 9.2.8 University Of California At San Diego Cartilage Regeneration Device 114 10 Clinical Trials To Watch 115 10.1 Overview 115 10.2 Can Shoulder Arthroscopy Work (csaw) Study 115 10.3 Arthroscopy In The Treatment Of Degenerative Medial Meniscus Tear 115 10.4 Knee Arthroscopy Cohort Southern Denmark 116 10.5 Hip Arthroscopy Versus Conservative Management Of Femoroacetabular Impingement 116 10.6 Femoroacetabular Impingement Randomized Controlled Trial 117 10.7 Multicenter Acl Revision Study (mars) 117 10.8 Arthroscopic Versus Open Stabilization For Traumatic Shoulder Instability 118 10.9 Microfracture In The Knee Study 118 10.10 Single- Versus Double-row Suture Anchor Repair In Medium To Large Rotator Cuff Tears 119 10.11 Early Surgery Versus Conservative Therapy For Meniscal Injuries In Older Patients (escape) 119 10.12 Arthroscopic Rotator Cuff Repair Of Full Thickness Tears With And Without Arthroscopic Acromioplasty 120 10.13 Arthroscopic Rotator Cuff Repair With Platelet-rich Plasma 121 10.14 Tibial Tunnel Widening In Acl Reconstruction-comparing Two Bioscrews 121 11 Current And Future Players 122 11.1 Trends In Corporate Strategy 122 11.2 Company Profiles 123 11.2.1 Arthrex 123 11.2.2 Arthrocare Corporation 125 11.2.3 Biomet 127 11.2.4 Conmed Corporation 130 11.2.5 Depuy Companies 132 11.2.6 Smith & Nephew 134 11.2.7 Stryker 136 11.2.8 Tornier 138 11.2.9 Wright Medical Group 141 11.2.10 Other Key Players In Sports Medicine 144 12 Market Outlook 149 12.1 Company Market Share 149 12.1.1 Overview 149 12.1.2 Us 149 12.2 Us Market Outlook 150 13 Appendix 153 13.1 Bibliography 153 13.2 Abbreviations 162 13.3 Research Methodology 166 MediPoint: Sports Medicine - US Analysis and Market Forecasts
  • 4. 13.3.1 Overview 166 13.3.2 Coverage 166 13.3.3 Secondary Research 166 13.4 Physicians And Specialists Included In This Study 167 13.4.1 Dr. Henry D.e. Atkinson 167 13.4.2 Dr. Joshua Alpert 167 13.4.3 Dr. Andrea Ferretti 167 13.4.4 Dr. Alejandro Gonzalez Della Valle 168 13.4.5 Dr. Andreas Imhoff 168 13.4.6 Dr. Marcello Zaia Oliveira 168 13.4.7 Dr. Vidhya Ravi 168 13.4.8 Dr. Elvire Servien 168 13.4.9 Dr. Yotaro Yamakado 168 13.5 Primary Research 169 13.5.1 Primary Research - Key Opinion Leader Interviews 169 13.5.2 Primary Research - Physician And Industry Interviews 169 13.5.3 Expert Panel Validation 170 13.6 Forecasting Methodology 170 13.7 About The Authors 172 13.7.1 Analysts 172 13.7.2 Global Head Of Healthcare 173 13.8 About Medipoint 174 13.9 About Globaldata 174 13.10 Disclaimer 174 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ MediPoint: Sports Medicine - US Analysis and Market Forecasts